UK-based Peli BioThermal, the life science industry’s partner from discovery to distribution, has announced an exp...
Australian biotechnology leader CSL has announced that the European Commission has granted conditional marketing authori...
Lunit, a global provider of artificial intelligence (AI)-powered cancer solutions, has announced its decision to establi...
Japan headquartered pharmaceutical company Shionogi & Co. and its European subsidiary, Shionogi B.V. have announced ...
The International Vaccine Institute (IVI), based in Seoul (South Korea) has launched an IVI Country Office in&...
Tokyo Headquarterd Kaneka Corporation is set to increase its GMP manufacturing capacity for mRNA in ...
Novotech, headquartered in Australia, has announced the acquisition of EastHORN, a European contract research organisati...
India’s Bangalore based Indegene, a digital-first, life sciences commercialization company, has launched a n...
BioNTech SE and InstaDeep Ltd. have entered partnership under which BioNTech will acquire InstaDeep to build AI-driven d...
In one word, how would you describe 2022? I would describe it as volatile, which means it was very difficult to...
Japanese pharmaceutical firm Takeda has announced that the European Commission (EC) has granted marketing authorisation ...
Shionogi has officially opened the doors to its new European headquarters in Herengracht, Amsterdam, marking the next st...
China-based startup Scivita Medical Technology and Fujifil Europe B.V., headquartered in the Netherlands, have join...
Headquartered in Germany, Vetter, a global contract development and manufacturing organisation (CDMO), has announced the...
CHEPLAPHARM AG, a leading international platform for well-established branded medicines, has entered into a definitive a...
Germany-based Sartorius has entered a research partnership with The BASE Facility at The University of Queensl...
Agilent Technologies Inc. has announced the opening of the Dissolution Centre of Excellence (CoE) facility in Crave...
Japanese pharmaceutical firm Takeda has announced that the Committee for Medicinal Products for Human Use...
